Close

Leerink Partners Raises Price Target on ZELTIQ Aesthetics (ZLTQ) to $48; Reiterates Outperform

Go back to Leerink Partners Raises Price Target on ZELTIQ Aesthetics (ZLTQ) to $48; Reiterates Outperform

ZELTIQ Announces Second Quarter 2016 Financial Results

August 8, 2016 4:05 PM EDT

PLEASANTON, CA -- (Marketwired) -- 08/08/16 -- ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ)

Second quarter revenue of $89.5 million, up 39% year-over-year364 systems shipped, bringing total installed base to 5,254 systems370,122 revenue cycles shipped, up 47% year-over-yearSecond quarter cash generation of $13.4 million

ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products... More

ZELTIQ Aesthetics, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference

August 5, 2016 9:00 AM EDT

PLEASANTON, CA -- (Marketwired) -- 08/05/16 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Taylor Harris, Senior Vice President and Chief Financial Officer, is scheduled to present at the Canaccord Genuity 36th Annual Growth Conference in Boston, MA.

... More